Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KNUDSEN ØSTERGAARD KIROPRAKTISK KLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   1.7% 0.7% 0.8% 0.7% 0.8% 0.8% 11.3% 11.3%   Credit score (0-100)   74 95 93 93 92 89 22 22   Credit rating   A AA AA AA AA A BB BB   Credit limit (kDKK)   4.0 509.7 650.4 619.3 528.3 571.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,976 4,000 4,787 4,316 4,625 5,617 0.0 0.0   EBITDA   49.6 1,132 1,758 844 789 1,951 0.0 0.0   EBIT   8.5 1,089 1,711 785 660 1,841 0.0 0.0   Pre-tax profit (PTP)   -21.1 1,031.3 1,645.3 677.7 626.9 1,911.7 0.0 0.0   Net earnings   -17.1 790.3 1,289.6 527.5 490.3 1,489.0 0.0 0.0   Pre-tax profit without non-rec. items   -21.1 1,031 1,645 678 627 1,912 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   191 148 200 140 430 321 0.0 0.0   Shareholders equity total   1,762 2,553 3,342 3,370 3,360 4,349 724 724   Interest-bearing liabilities   1,038 1,019 1,172 1,212 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,313 4,412 5,654 5,315 4,107 5,330 724 724   Net Debt   -2,315 -2,556 -3,610 -3,427 -3,025 -1,838 -724 -724     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,976 4,000 4,787 4,316 4,625 5,617 0.0 0.0   Gross profit growth   8.2% 0.6% 19.7% -9.8% 7.2% 21.5% -100.0% 0.0%   Employees   0 0 0 0 0 6 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,313 4,412 5,654 5,315 4,107 5,330 724 724   Balance sheet change%   34.2% 2.3% 28.2% -6.0% -22.7% 29.8% -86.4% 0.0%   Added value   49.6 1,132.3 1,758.3 844.5 719.1 1,950.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   139 -86 5 -118 160 -219 -321 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.2% 27.2% 35.7% 18.2% 14.3% 32.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.2% 25.0% 34.0% 14.3% 14.0% 40.6% 0.0% 0.0%   ROI %   0.3% 34.2% 42.3% 17.3% 16.6% 49.6% 0.0% 0.0%   ROE %   -0.8% 36.6% 43.8% 15.7% 14.6% 38.6% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   40.9% 57.9% 59.1% 63.4% 81.8% 81.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -4,662.7% -225.8% -205.3% -405.9% -383.2% -94.2% 0.0% 0.0%   Gearing %   58.9% 39.9% 35.1% 36.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.3% 5.7% 6.0% 9.0% 5.4% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.6 2.5 2.7 2.8 5.7 8.6 0.0 0.0   Current Ratio   1.6 2.5 2.7 2.8 5.7 8.6 0.0 0.0   Cash and cash equivalent   3,352.8 3,575.2 4,782.5 4,639.6 3,025.2 1,838.0 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,431.6 2,483.7 3,358.3 3,175.2 2,843.6 4,222.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 325 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 325 0 0   EBIT / employee   0 0 0 0 0 307 0 0   Net earnings / employee   0 0 0 0 0 248 0 0